0001742961-18-000001.txt : 20180614 0001742961-18-000001.hdr.sgml : 20180614 20180614102726 ACCESSION NUMBER: 0001742961-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180614 DATE AS OF CHANGE: 20180614 EFFECTIVENESS DATE: 20180614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palvella Therapeutics, Inc. CENTRAL INDEX KEY: 0001742961 IRS NUMBER: 812228053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-314592 FILM NUMBER: 18898450 BUSINESS ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 800-484-0260 MAIL ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 D 1 primary_doc.xml X0708 D LIVE 0001742961 Palvella Therapeutics, Inc. 125 STRAFFORD AVENUE STE 360 WAYNE PA PENNSYLVANIA 19087 800-484-0260 DELAWARE None None Corporation true 2015 Wesley H. Kaupinen 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Michael Christopher 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Todd Davis 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Timothy Henkel 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Elaine Heron 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director George Jenkins 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director David Tierney 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Biotechnology Decline to Disclose 06b false 2018-05-31 false true false 0 5000000 4439504 560496 false 40 0 0 0 false Palvella Therapeutics, Inc. /Wesley H. Kaupinen/ Wesley H. Kaupinen President and CEO 2018-06-14